Differences in quality of life among patients receiving dialysis replacement therapy at seven medical centers

Benjamin Mozes*, Esther Shabtai, David Zucker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

The purpose of this study is to investigate the variations in quality of life (QOL) among patients with end-stage renal disease (ESRD) who are receiving replacement therapy in several dialysis centers. This observational study includes interviews with nurses and data extraction from medical charts for all 680 adults who had been on dialysis therapy for more than 4 weeks in seven dialysis centers. By using multivariate analysis, we generated a model to explain the variance in QOL as measured by the QL index score among patients pooled from all centers. The expected mean QL index score and 95% confidence interval were computed for each dialysis center. Centers with observed mean QL index scores outside of the expected confidence range were marked as possible outliers. We found the following patient attributes to be independently associated with QOL: age, education, occupation, and certain comorbidities (e.g., diabetes, stroke). After adjustment for case mix, we could identify four outlier centers. After further adjustment for albumin in serum, a possible process indicator, two centers were no longer considered as outliers. These findings indicate that the variance in QOL of ESRD patients at different centers is not entirely explained by known case-mix factors. Further research should explore whether such variations are related to dissimilarity in the process of care at different centers.

Original languageEnglish
Pages (from-to)1035-1043
Number of pages9
JournalJournal of Clinical Epidemiology
Volume50
Issue number9
DOIs
StatePublished - 1997

Keywords

  • Dialysis
  • ESRD
  • Hemodialysis
  • Outcome
  • Peritoneal
  • Quality of life

Fingerprint

Dive into the research topics of 'Differences in quality of life among patients receiving dialysis replacement therapy at seven medical centers'. Together they form a unique fingerprint.

Cite this